Federal contract award
75A50124F61016
ACQUISITION OF EGG-BASED INFLUENZA MASTER AND WORKING SEED LOTS DERIVED FROM A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345-001/2021 (H5N1) CANDIDATE VACCINE VIRUS AND FILL-FINISH OF ANY EXISTING EGG-BASED A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345/20
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 75A50122D00002 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.7M |
| Current contract value | $1.7M |
| Potential contract value / ceiling | $1.7M |
| Start date | Aug 30, 2024 |
| Current end date | Feb 21, 2026 |
| Potential end date | Feb 21, 2026 |
| Latest award activity | Mar 26, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 26, 2025 | P00002 | $0 | THIS TASK ORDER ESTABLISHES SERVICES FOR THE ACQUISITION OF MEDICAL COUNTERMEASURES (MCMS) FOR PANDEMIC INFLUENZA AND EMERGING DISEASES PREPAREDNESS AND RESPONSE UNDER CONTRACT 75A50122D00002. |
| Feb 12, 2025 | P00001 | $0 | THIS TASK ORDER ESTABLISHES SERVICES FOR THE ACQUISITION OF MEDICAL COUNTERMEASURES (MCMS) FOR PANDEMIC INFLUENZA AND EMERGING DISEASES PREPAREDNESS AND RESPONSE UNDER CONTRACT 75A50122D00002. |
| Aug 23, 2024 | 0 | $1.7M | ACQUISITION OF EGG-BASED INFLUENZA MASTER AND WORKING SEED LOTS DERIVED FROM A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345-001/2021 (H5N1) CANDIDATE VACCINE VIRUS AND FILL-FINISH OF ANY EXISTING EGG-BASED A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345/20 |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.